Related references
Note: Only part of the references are listed.Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
Seung-Hyeon Seok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The Aryl Hydrocarbon Receptor and Tumor immunity
Ping Xue et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
Arum Park et al.
FRONTIERS IN IMMUNOLOGY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
STATs in NK-Cells: The Good, the Bad, and the Ugly
Dagmar Gotthardt et al.
FRONTIERS IN IMMUNOLOGY (2017)
Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection
Xavier Dagenais-Lussier et al.
JOURNAL OF VIROLOGY (2016)
Regulation of Natural Killer Cell Function by STAT3
Nicholas A. Cacalano
FRONTIERS IN IMMUNOLOGY (2016)
Research progress of indoleamine 2,3-dioxygenase inhibitors
Tianze Jiang et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
Michael Platten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
Dagmar Gotthardt et al.
BLOOD (2014)
Natural cytotoxicity receptors and their ligands
Philip H. Kruse et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike M. Litzenburger et al.
ONCOTARGET (2014)
Natural killer cells: multifaceted players with key roles in hepatitis C immunity
Lucy Golden-Mason et al.
IMMUNOLOGICAL REVIEWS (2013)
The aryl hydrocarbon receptor in innate T cell immunity
Joerg Stange et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCRαβ+ CD8αα+ cells
Kohei Nakajima et al.
NATURE COMMUNICATIONS (2013)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
Romain Bedel et al.
CANCER RESEARCH (2011)
Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages
Kazuya Masuda et al.
INTERNATIONAL IMMUNOLOGY (2011)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Srinivas S. Somanchi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
Lionel Apetoh et al.
NATURE IMMUNOLOGY (2010)
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Masahiro Matsui et al.
CANCER RESEARCH (2009)
Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
Marc Veldhoen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Mirna Balsamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The aryl hydrocarbon receptor in immunity
Charlotte Esser et al.
TRENDS IN IMMUNOLOGY (2009)
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D
Mathias Krockenberger et al.
JOURNAL OF IMMUNOLOGY (2008)
Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells
Akihiro Kimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor
Sun-Hee Kim et al.
MOLECULAR PHARMACOLOGY (2006)
IL-21 enhances tumor rejection through a NKG2D-dependent mechanism
R Takaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo
CAJ Vosshenrich et al.
JOURNAL OF IMMUNOLOGY (2005)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
DNA binding specificity of different STAT proteins -: Comparison of in vitro specificity with natural target sites
GB Ehret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells
CA O'Callaghan
CLINICAL SCIENCE (2000)
The Jak-STAT pathway
K Imada et al.
MOLECULAR IMMUNOLOGY (2000)